Production (Stage)
Eastwood Bio-Medical Canada Inc.
EBM.V
TSX
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.48% | 36.80% | -1.93% | -38.59% | -39.59% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.48% | 36.80% | -1.93% | -38.59% | -39.59% |
| Cost of Revenue | -12.89% | 1.02% | -9.11% | -47.59% | -29.25% |
| Gross Profit | 7.70% | 94.78% | 1.59% | -31.94% | -43.19% |
| SG&A Expenses | -18.21% | 4.93% | -7.17% | -30.82% | -38.29% |
| Depreciation & Amortization | 60.41% | 1.51% | -3.47% | -1.51% | -1.50% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -9.06% | 3.48% | -7.24% | -32.91% | -33.83% |
| Operating Income | 42.80% | 25.46% | 16.05% | 24.40% | 4.91% |
| Income Before Tax | 27.86% | 15.84% | 3.98% | 26.12% | 21.79% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 27.86% | 15.84% | 3.98% | 26.12% | 21.79% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 27.86% | 15.84% | 3.98% | 26.12% | 21.79% |
| EBIT | 42.80% | 25.46% | 16.05% | 24.40% | 4.91% |
| EBITDA | 118.66% | 28.19% | 2.84% | 17.10% | 7.27% |
| EPS Basic | 33.33% | 15.00% | 7.69% | 26.32% | 14.29% |
| Normalized Basic EPS | 25.00% | 16.67% | 0.00% | 25.00% | 20.00% |
| EPS Diluted | 33.33% | 15.00% | 7.69% | 26.32% | 14.29% |
| Normalized Diluted EPS | 25.00% | 16.67% | 0.00% | 25.00% | 20.00% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |